CUV 1.85% $13.28 clinuvel pharmaceuticals limited

...so the fda denied a ph iii attempt

  1. 648 Posts.
    Disappointing that the FDA apparently denied Clinuvel's attempt to jump to a Phase III trial in the US, especially given Phase III is over in Europe.

    This will delay a US launch for another year.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.28
Change
-0.250(1.85%)
Mkt cap ! $664.8M
Open High Low Value Volume
$13.55 $13.62 $13.25 $1.157M 86.45K

Buyers (Bids)

No. Vol. Price($)
1 227 $13.28
 

Sellers (Offers)

Price($) Vol. No.
$13.42 228 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.